📊 MET-PF Key Takeaways
Is Metlife Inc. (MET-PF) a Good Investment?
MetLife demonstrates solid operational fundamentals with strong free cash flow generation ($17.1B) and healthy interest coverage (8.5x), though profitability metrics reveal modest returns with 4.4% net margin and 0.5% ROA. The extraordinary revenue growth (+3064.4% YoY) appears anomalous and warrants investigation into accounting changes or acquisitions, but underlying operational cash generation and moderate leverage (0.66x debt/equity) support financial stability.
Why Buy Metlife Inc. Stock? MET-PF Key Strengths
- Strong free cash flow of $17.1B with 22.2% FCF margin indicating robust cash generation capability
- Conservative leverage with 0.66x debt/equity ratio and solid 8.5x interest coverage ratio
- Substantial cash position of $22.0B providing financial flexibility and cushion
- Positive net income growth (+6.5% YoY) with stable 11.9% ROE for capital returns
MET-PF Stock Risks: Metlife Inc. Investment Risks
- Extremely low ROA of 0.5% indicates poor asset efficiency relative to $745.2B asset base
- Diluted EPS declined 20.7% YoY despite net income growth, suggesting significant share dilution or capital structure changes
- Abnormal revenue spike (+3064.4% YoY) lacks clarity and may mask operational headwinds or one-time items
- Net margin of 4.4% and operating margin of 8.0% remain compressed for insurance industry standards
Key Metrics to Watch
- Operating margin trend and sustainability of 8.0% level
- Free cash flow generation consistency and capital allocation decisions
- Return on equity trajectory and shareholder value creation relative to industry peers
- Asset efficiency improvements and ROA expansion toward industry benchmarks
- Debt/equity ratio stability and debt service capacity under stress scenarios
Metlife Inc. (MET-PF) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The 22.2% free cash flow margin provides substantial flexibility for dividends, buybacks, and strategic investments. The current ratio below 1.0x warrants monitoring of short-term liquidity.
MET-PF Profit Margin, ROE & Profitability Analysis
MET-PF vs Finance Sector: How Metlife Inc. Compares
How Metlife Inc. compares to Finance sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Metlife Inc. Stock Overvalued? MET-PF Valuation Analysis 2026
Based on fundamental analysis, Metlife Inc. has mixed fundamental signals relative to the Finance sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Metlife Inc. Balance Sheet: MET-PF Debt, Cash & Liquidity
MET-PF Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Metlife Inc.'s revenue has grown significantly by 17% over the 5-year period, indicating strong business expansion. The most recent EPS of $1.81 reflects profitable operations.
MET-PF Revenue Growth, EPS Growth & YoY Performance
MET-PF Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $554.0M | $896.0M | $1.22 |
| Q2 2025 | $558.0M | $729.0M | $1.03 |
| Q1 2025 | $577.0M | $867.0M | $1.10 |
| Q3 2024 | $554.0M | $489.0M | $0.56 |
| Q2 2024 | $546.0M | $402.0M | $0.48 |
| Q1 2024 | $562.0M | $80.0M | $0.02 |
| Q3 2023 | $511.0M | $489.0M | $0.56 |
| Q2 2023 | $525.0M | $402.0M | $0.48 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Metlife Inc. Dividends, Buybacks & Capital Allocation
MET-PF SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Metlife Inc. (CIK: 0001099219)
📋 Recent SEC Filings
❓ Frequently Asked Questions about MET-PF
What is the AI rating for MET-PF?
Metlife Inc. (MET-PF) has an AI rating of BUY with 72% confidence, based on fundamental analysis of SEC EDGAR filings.
What are MET-PF's key strengths?
Claude: Strong free cash flow of $17.1B with 22.2% FCF margin indicating robust cash generation capability. Conservative leverage with 0.66x debt/equity ratio and solid 8.5x interest coverage ratio.
What are the risks of investing in MET-PF?
Claude: Extremely low ROA of 0.5% indicates poor asset efficiency relative to $745.2B asset base. Diluted EPS declined 20.7% YoY despite net income growth, suggesting significant share dilution or capital structure changes.
What is MET-PF's revenue and growth?
Metlife Inc. reported revenue of $77.1B.
Does MET-PF pay dividends?
Metlife Inc. pays dividends, with $1,509.0M distributed to shareholders in the trailing twelve months.
Where can I find MET-PF SEC filings?
Official SEC filings for Metlife Inc. (CIK: 0001099219) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is MET-PF's EPS?
Metlife Inc. has a diluted EPS of $4.71.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is MET-PF a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Metlife Inc. has a BUY rating with 72% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.
Is MET-PF stock overvalued or undervalued?
Valuation metrics for MET-PF: ROE of 11.9% (sector avg: 12%), net margin of 4.4% (sector avg: 25%). Compare these metrics with sector averages to assess valuation.
Should I buy MET-PF stock in 2026?
Our dual AI analysis gives Metlife Inc. a combined BUY rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is MET-PF's free cash flow?
Metlife Inc.'s operating cash flow is $17.1B, with capital expenditures of N/A. FCF margin is 22.2%.
How does MET-PF compare to other Finance stocks?
Vs Finance sector averages: Net margin 4.4% (avg: 25%), ROE 11.9% (avg: 12%), current ratio N/A (avg: 1.2).